Medicine Manufacturing Cost in India: Practical Ways Pharma Companies Are Protecting Margins in 2026
The medicine manufacturing cost in India has become one of the toughest line items for generic drug makers to control. Between volatile active pharmaceutical ingredient (API) prices, the updated Schedule M compliance norms, and rising energy bills, even well-run formulation units are watching margins shrink. Yet the manufacturers who treat cost control as a process, not a one-time fix, are the...
0 Comments 0 Shares 98 Views 0 Reviews
Sponsored